| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.00049 | 1 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.00033 | 1 |